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Exposure of rabbit pulmonary arterial smooth muscle cells to the calcium ionophorc A23187. dose-dependently stimulates arachidonic acid (AA) 
release and phospholipase 4 (PL&) activity. The protein kinase C (PKC) inhibitor, sphingosine does not prevents AA release and PLA, activity 
caused by low doses of A23187. In conteast, sphingosinc markedly prevents AA release and PLA, activity caused by higher doses of A23187. PKC 
activity profile indicates that treatment of the cells with low doses of A23 187 does not cause significant alteration of PKC translocation from cytosol 
to membrane whereas higher concentrations of the ionophorc dose-dependently enhance PKC translocation from cytosol to membrane in the 
smooth muscle cells. 
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1. INTRODUCTION 2. MATERIALS AND METHODS 
The salcium ionophore, A23187 is a widely accepted 
agent used as a probe to study the calcium signalling 
phenomena in cells and tissues. A23187 was shown to 
stimulate release of AA and its metabolites in the 
presence of extracellular calcium in various types of 
cells [l-3]. Studies on different types of cells indicated 
that protein kinase C activators potentiate the effect of 
calcium ionophore to release AA and its metabolites 
[4-61. One of the steps that would require the participa- 
tion of protein kinase C might occur at the level at 
which AA is released from its phospholipid stores upon 
stimulation of PLA2 [4], a calcium activated enzyme 
171. In view of this, and to gain insight into the calcium 
signalling phenomena caused by a caicium ionophore, 
A23187 was used to stimulate AA release and PLA2 ac- 
tivity, and the precise role of protein kinase C in this 
scenario in rabbit pulmonary arterial smooth muscle 
cells is determined in this present investigation. 
Abbreviations: AA, arachidonic acid; PLAz, phospholipase AZ; 
A23187, calcium ionophore; PKC, protein kinase C; PBS, phosphate 
buffered saline; FCS, fetal calf serum; HEPES, 4-(2-hydroxyethyl)- 
I-piperazine N-t-ethanesulfonate; ATP, adenosine triphosphate; 
HBPS, Hank’s buffered physiological solution. 
Correspondence address: S. Chakraborti, Department of 
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2.1. Heagen ts 
HBPS, DMEM, FCS, PBS without Ca” and Mg”, and trypsin 
were purchased from GlBCO laboratories (Grand Island. NY). 
Sphingosine, HEPES, calcium ionophore (A23187), fatty-acid-free 
bovine serum albumin, dithiothreitol, ATP. leupeptin, histone type 
Ills, collagenase. and type 1 porcine pancreatic elastase were obtained 
from Sigma Chemical Co., St. Louis, MO. [%]Arachidonic acid, the 
radiolabelled phospholipid L-3-phosphatidyl choline, L-1-stearoyl-2 
[ I-‘JC]arachidonyl and [y-“PJATP were obtained from New England 
Nuclear, Wilmington, DE. All other chemicals used were of analytical 
grade. 
2.2. Cell culrirre 
The pulmonary arterial smooth muscle cells of rabbit were isolated 
by following the method of Ross [S] with some modifications. Briefly, 
the main pulmonary artery and its bifurcation were isolated and plac- 
ed in HBPS to remove the blood cells. The artery was incubated at 
37°C in a collagenasc and elastase mixture (1 mg/ml of collagenase 
plus 0.25 mg/ml of type 1 porcine pancreatic elastase). After incuba- 
tion for 30 min, the tissue was minced into l-3 mm’ pieces with 
scalpel blades. The tissue was incubated for an additional two hours 
with fresh enzyme added every 30 min. The solution was filtered 
through sterile 100 .U mesh and centrifuged at 100 x g for 5 min at 
4’C. The cells were then placed in DMEM with 20% fetal calf serum, 
100 units of streptomycin and penicillin, L-glutamine, non-essential 
amino acids and 1.5 g sodium bicarbonate per liter. Medium was 
changed 3 times per week. Cells were subcultured after treatment wit:1 
0.25% trypsin. Cells were studied between passages 7and 12. All ex- 
periments were performed on confluent monolayers and in serum-free 
media supplemented with fatty-acid-free bovine serum albumin (1 
mg/ml). 
2.3. MeasurenmIs of f4C/AA release and PLA.z activity 
Cells grown in six-well plates (Costar) were washed twice with PBS 
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(pH 7.2)and incubated for 20 h with [‘JC]arachidonic acid (sp. activi- 
ty 54.G mCi/mmol; 2 @/well). After incubation, the supernatant 
was removed and the cells were washed twice with PBS. To measure 
A23187-induced AA release, cells were exposed to different concen- 
trations of A23187 for 10 min. The medium was then removed and 
AA release was measured following the method of Chakreborti et al. 
191. To determine A23187-induced PLAz activity, the smooth muscle 
cells grown in six-well plates (Costar) were incubated with different 
concentrations of the ionophore A23187, for 10 min. After incuba- 
tion, the monolayers were washed twice with PBS (pH 7.2). The cells 
were then removed from PBS with a rubber policeman and centrifug- 
ed in a microfuge at 12 000 x g for 2 min at room temperature. The 
pellet was suspended in PBS and disrupted by sonication in a cell 
sonifier. Twenty microliters of the broken cell preparation (l-3 mg 
protein - IO’ cells) were added to 30 pl of the reaction mixture, which 
contained (final concentrations): Tris-hydroxymethylaminomethane 
(Tris) buffer (100 pM), NaCl (IO0 mM). deoxycholate (I mM) and the 
phospholipid L-3-phosphatidyl choline-L-I-stearoyl-2-[1-“Clarachi- 
donyl (sp. activity 58.3 mCi/mmol; 10 FM). Phospholipase AZ activi- 
ty was assayed at pH 9.0 following the method of Chakraborti et al. 
[91. To determine the optimum concentration of sphingosine to in- 
hibit stimulation of AA release caused by A23187, cells were 
pretreated with different concentrations of sphingosine for 20 min 
before addition of lOaM of the ionophore for IO min, and AA release 
was measured. To determine the effect of sphingosine on 
A23187-induced AA release and PLA2 activity, the cells were 
pretreated with sphingosine (I5 PM) for 20 min before exposure to 
different concentrations of the ionophore for IO min. and AA release 
and PLAz activity were measured. 
2.4. Meuswernent of protein kinase C activity 
The smooth muscle cells grown in T-150 flasks were washed twice 
with PBS (pi-l 7.2) and incubated in DMEM supplemented with I 
mg/ml fatty-acid-free bovine serum albumin for 10 min. The medium 
was then removed and the cells washed with ice-cold homogenizing 
medium (containing 20 mM HEPES-NaOH (pH 7.4), 5 mM EGTA, 
3 mM MgCl2,O.l Vo fatty-acid-free bovine serum albumin). The cells 
were then scraped from the flasks and disrupted by sonication with a 
cell sonifier and centrifuged at 100 000 x g for I h at 4’C. The pro- 
tein concentration of the supernatant fraction was maintained at I 
mg/ml with the homogenizing medium and this fraction was used as 
the cytosolic fraction. The pellet was then resuspended in ice-cold 
homogenizing buffer containing 0.1% Triton X-100. After sonica- 
tion, the pellet was kept at 4°C with constant shaking for I hand then 
centrifuged at 100 000 x g for 1 h at 4°C. The supernatant fraction 
\\as used as the membrane fraction and protein concentration was 
maintained at 1 mg/ml with the homogenizing medium that was sup- 
plemented with Triton X-100 (0.1070). Protein kinase C activity was 
determined following the method of Kitano et al. [lo] with some 
modifications, Briefly, a 20 ml aliquot of the sample of the cytosolic, 
or membrane fraction was added to 80 /rl of the reaction mixture con- 
taining 25 mM HEPES-NaOH (pH 7.4). 2 mM DTT, 20 PM ATP, 0.2 
mg/ml histone type Ills, IO PM [y-‘ZP]ATP (SO-100 cpm/pmol) with 
or without 1.5 mM CaCl2, 25 ~g/ml phosphatidyl serine, and 0.5 
&ml diolein. Incubation was performed at 30°C for 10 min. The 
reaction was terminated with the addition of I ml of ice-cold stopping 
solution containing 10% TCA and 2 mM ATP, followed by the addi- 
tion of 100 pl of 0.50/, fatty-acid-free bovine serum albumin. The 
precipitated protein was trapped on a millipore HA filter. The filter 
was washed 5 times, each time with 3 ml of cold So;0 TCA, and dried. 
The radioactivity remaining on the filter was determined by subtrac- 
ting the activity measured in the absence of calcium and the 
phospholipid from that measured in their presence for both cytosol 
and membrane fractions. 
To determine the effect of different concentrations of A23187 on 
protein kinase C activity, the smooth muscle cells were treated with 
different concentrations of the ionophore for 10 min, and protein 
kinase C activity in the cytosol and membrane fractions was deter- 
mined. 
2.5. Cell viability 
None of the agents used in this present study affected the cell 
viability as assessed by Trypan blue exclusion. 
2.6. Statistical analysis 
Data were analyzed by unpaired t-test, repeated measures analysis 
of variance, and the Duncan multiple range test for group com- 
parisons. Statistical significance was assumed when P ~0.05 [I I]. 
3. RESULTS AND DISCUSSION 
The calcium ionophore, A23187 dose-dependently 
stimulates AA release and PLAz activity in rabbit 
pulmonary arterial smooth muscle cells (Fig. 1). The 
stimulation of AA release and PEA2 activity were deter- 
mined to be optimum at 10 PM of the ionophore 
(A23187) treatment to the cells (Fig. 1). This implies 
that the induction of PLAt activity resulting in the 
stimulation of AA release must require a rise in in- 
tracellular calcium concentration, and that a calcium- 
sensitive component could be involved in the calcium 
ionophore-mediated stimulation of AA release and 
PLA2 activity in the smooth muscle cells. The require- 
ment of protein kinase C for stimulation of AA release 
and PLA2 activity in the cells under A23 187 exposure is 
determined by a protein kinase C inhibitor, sphin- 
gosine. Sphingosine was demonstrated to inhibit pro- 
tein kinase C activity in in vitro systems [ 12,131. The op- 
timum concentration (10 PM) of sphingosine required 
to produce its maximum inhibitory effect on 
A23 187~induced AA release was determined to be of 15 
FM (Fig. 2). Sphingosine does not prevent AA release 
and PLAt activity caused by low doses of A23 187 (Fig. 
1). In contrast, the stimulation of AA release and PEA2 
activity caused by higher doses of A23187 was deter- 
mined to be markedly prevented by sphingosine (Fig. 
1). It also appears from the present study that treatment 
of the cells with low doses of A23187 does not 
significantly stimulate protein kinase C translocation 
from cytosol to membrane (Table I), whereas higher 
doses of the ionophore dose-dependently stimulate pro- 
tein kinase C translocation from cytosol to membrane 
(Table I). Overall, from the present observations we 
conclude that there are 2 distinct mechanisms for ac- 
tivation of PLA2 activity which occur under A23 187 ex- 
posure in pulmonary arterial smooth muscle cells. The 
potent one occurs under higher doses of A23187 treat- 
ment with the involvement of protein kinase C, and the 
minor contribution to a marginal activation of PLA2 
happens as a result of a small rise in intracellular 
calcium caused by low doses of the ionophore treatment 
and does not occur through the involvement of protein 
kinase C dependent mechanism(s). Protein kinase C 
may stimulate AA release and PLAz activity by several 
possible mechanisms including activation of PLAz by 
phosphorylation [14], regulation of PLAz stimulatory 
proteins [ 151, or regulation of PLA2 inhibitory proteins 
such as lipocortins [163. 
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Fig. I. Effect of sphingosine on AA release (A) and PLAz activity (B) caused by different concentrations of calcium ionophore (A23 187) in rabbit 
pulmonary arterial smooth muscle cells. 0, Calcium ionophore (A23 I87)-mediated AA release (A), and PLAz activity (8); A, Sphingosine (15 l&M)- 
induced effect on calcium ionophore (A23187)-mediated AA release (A), and PLAz activity (B). Results are means t SE 01=4); *P<O.OS com- 
pared to control; **PcO.OOl compared to control; tPeO.05 compared to respective treatment A23187; $P<O.OOl compared to respective treat- 
ment A23187. Percent decrease in (A) AA release by sphingosine (15 PM) over the response produced by different concentrations of calcium 
ionophore (A23187): a, 7%; b. 6%: c, 10%; d, 19%; e, 38%; f, 61%; g, 72%; h, 84%; i, 92%; j, 96%; k, 96%; 1, 96%. (Percent change in AA 
release caused bysphingosine (15 PM) over control, 2Vo.) [AA release (cpm/lOs cells) produced: control, 41Ok42; sphingosine, 403 Z!Z 38.1 (B) PLA2 
activity by sphingosine (15 GM) over the response produced by different concentrations of calcium ionophore (A23187): a, 10%; b, 9%; c, 10%; 
d, 11%: e, 31%; f, 52%; g, 65%; h. 78%; i, 93%; j, 98%; k, 98%; 1, 98%. (Percent change in PLA2 activity caused by sphingosine (15 $M) over 
control, 3Vo.) (PLA2 activity (pmol AA/min/mg) produced: control, 3.12 f 0.28; sphingosine, 3.01 * 0.32.1 
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Fig. 2. Dose-response profile of sphingosine to prevent 
A23187-mediated AA release in rabbit pulmonary arterial smooth 
muscle cells. Results are mean f SE (n=4); *P<O.OS compared to 
control; **P<O.OOl compared to control. [AA release (cpm/105 cells) 
produced: control, 410?42 vs 10rtM of A23187, 1995 & 128.1 Percent 
decrease in AA release produced by different concentration of 
sphingosine over the response produced by 10 pM of A23 187: a, 11%; 
b, 25%; c, Gloio; d, 82%; e, 94%; f, 98%; g, 98%. 
Table 1 
Effect of different concentrations of the calcium ionophore (A23187) 
on the subcellular distribution of protein kinase C in rabbit 
pulmonary arterial smooth muscle cells 
Treatments Protein kinase C activity 
(pmol/min/mg) 
Cytosol Membrane Total 
None 1725 * 102 (90) 184 -c 34 (10) 1909 
A23187 (I PM) 1718 + 92 (91) 178 + 26 (9) 1896 
A23187 (2 1tM) 1712 rt 98 (90) 186 + 32 (10) 1898 
A23187 (3 jtM) 1706 zt 88 (90) 192 -1- 24 (10) 1898 
A23187 (4 /rM) 1563 -1- 74” (81) 362 -t 38” (19) 1925 
A23187 (5 pM 1328 + 78** (69) 594 -I- 45** (31) 1922 
A23187 (6 FM) 1196 -c 66” (62) 719 z!z 44** (38) 1915 
A23187 (7 pM) 1092 + 42** (57) 816 & 55** (43) 1908 
A23187 (8 /tM) 779 -t- 38** (40) 1145 rt 38** (60) 1924 
A23187 (9 /IM) 520 rf: 26”* (27) 1398 4 66** (73) 1918 
A23187 (IO PM) 349 k 32** (18) 1563 + 78** (82) 1912 
A23187 (11 PM) 356 f 26** (18) 1576 -t 56** (82) 1932 
A23187 (12 PM) 362 e 35** (19) 1552 e 64*’ (81) 1914 
Results are mean Z!Z SE (n = 4). Numbers in the parentheses represent 
percentages of protein kinase C in cytosol and membrane fractions of 
the smooth muscle cells. 
:iP<0.05 compared to control; **PcO.OOl compared to control 
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